BTI Biotechnology Institute

BTI Biotechnology Institute is a multinational company specialising in biomedicine whose activity focuses on three areas of work: regenerative medicine, oral implantology and sleep apnoea. Founded in 1999 by Dr. Eduardo Anitua, president and scientific director of the company, BTI is considered today to be a global scientific leader in regenerative medicine, having developed the technology of Plasma Rich in Growth Factors (Endoret® – PRGF®) and its various applications in multiple areas, from oral medicine to traumatology, sports medicine, dermatology, rheumatology, aesthetic medicine, ophthalmology and reproductive medicine. The company has a clear vocation for research, and is the biotechnology company to have had the highest scientific production in Spain in the last 8 years, according to the Spanish Association of Biocompanies (ASEBIO). It holds more than 50 international patents and 193 registered trademarks whose innovative products are manufactured in Spain and distributed across more than 50 countries. Since its foundation, BTI has reinvested 100% of its profits in research and development.